About HDI's Products
Events
Distributorship
News
Research Studies
Employment
Search
Contact Us
Legal/Section 16
Home
   

News
Current news, archives, research and investor news

• Current Press Releases

• 2002-1999 Archives

• Research Study Archives

• Investor News

2002-1999 Archives:
 

2002

Hypertension Diagnostics Announces Warrant Offering Results
November 20, 2002 –

Hypertension Diagnostics Shareholders Approve
Special Meeting Proposal; Company Meets
Conditions to Obtain Waiver of Certain Events of Default
October 25, 2002 –

Hypertension Diagnostics Secures Conditional
Waiver of Note Covenant Defaults
October 21, 2002 –

Hypertension Diagnostics Extends Warrant Offering and Class A Warrant to November 14, 2002; Exercise Price of Both Class A Warrant and Class B Warrant Reduced to $1.00
October 17, 2002 –

Hypertension Diagnostics Adjourns Special Meeting
until October 25, 2002
October 15, 2002 –

Hypertension Diagnostics Adjourns Special Meeting
until October 15, 2002
September 25, 2002 –

Hypertension Diagnostics Adjourns Special Meeting
until October 4, 2002
September 25, 2002 –

Arterial Elasticity Assessment and the Clinical
Applications of the CVProfilor^® to be Presented at Cardiovascular Meetings in China
September 12, 2002 –  

Hypertension Diagnostics Extends Warrant Offering to October 22, 2002
September 11, 2002 –

Hypertension Diagnostics to Conduct Direct-To-Consumer Test Market of its CVProfilor^® in Cooperation with Costco Wholesale Corporation
August 20, 2002 –

Hypertension Diagnostics’ CVProfilor^® to be Featured on the Ruth Koscielak Show during the Minnesota State Fair
August 15, 2002 –

Hypertension Diagnostics Continues Expansion of its Direct-to-Consumer Marketing of the CVProfilor^® through OnSite Wellness Medical Associates
August 12, 2002 –

Hypertension Diagnostics Establishes Distribution in India
July 23, 2002 –

Hypertension Diagnostics Adds Korean Distributor
June 27, 2002 –

Hypertension Diagnostics Begins Direct-to-Consumer
Offering of its CVProfilor^® DO-2020 System in U.S.
June 26, 2002 –

Hypertension Diagnostics Surpasses 100
CVProfilor^® DO-2020 System Placements in U.S.
June 25, 2002 –

Hypertension Diagnostics to Demonstrate CVProfilor^®
DO-2020 System at the Pri-Med Midwest Meeting in Illinois
June 20, 2002 –

Hypertension Diagnostics to Introduce the CVProfilor^®
MD-3000 System at the Scientific Meeting in Prague
June 19, 2002 –

Hypertension Diagnostics’ CVProfilor^® DO-2020
System Featured In Clinical Presentation at the
ADA's 62nd Scientific Session
June 17, 2002 –  

Hypertension Diagnostics Commences Warrant Offering: Reduces Exercise Price of Class A, Class B Warrant,
Extends Expiration Date of Class A Warrant
June 6, 2002 –       

Hypertension Diagnostics Technology Included in Key
Clinical Presentations at the World Cardiology Congress
May 29, 2002 –

Hypertension Diagnostics Sets New Record for the
Number of Clinical Presentations at the ASH Annual Meeting
May 9, 2002 –

Hypertension Diagnostics Announces Effectiveness
of Private Placement Registration Statement
April 30, 2002 –

CVProfilor^® System Drew Sizeable Attention at
American College of Cardiology Conference
April 16, 2002 –

Stanford University Invites Hypertension Diagnostics to Demonstrate CVProfilor^® System at Cardiovascular
Nutrition Conference
April 10, 2002 –

Hypertension Diagnostics Announces Warrant Offering
April 5, 2002 –

Hypertension Diagnostics to Demonstrate CVProfilor^®
System at the ACP-ASIM Annual Conference
April 4, 2002 –

Hypertension Diagnostics raises $2 million from private placement
March 27, 2002 –

2001

Hypertension Diagnostics' CVProfilor^® DO-2020 System
Featured In Disease Management Advisor Newsletter
December 6, 2001 –

Hypertension Diagnostics Announces Investor Conference Call
November 26, 2001 –

Minnesota Timberwolves^® Utilize Hypertension Diagnostics’ CVProfilor^® for Annual Physical Examinations
October 16, 2001 –

Hypertension Diagnostics' CVProfilor^® DO-2020 System
Featured in Medical Bulletin Sent to American Academy of Family Physicians
October 2, 2001 –

Hypertension Diagnostics Expands U.S. Distribution Network for its CVProfilor^® DO-2020 System
September 27, 2001 –

Makefield Securities Corporation Initiates Equity Research Coverage of Hypertension Diagnostics
September 25, 2001 –

Hypertension Diagnostics' CVProfilor^® Selected by
HealthEast Care System For Use in Its Family Practice
and Internal Medicine Clinics
September 7, 2001 –

Hypertension Diagnostics to Present at August 14
Bluefire Research Investor Conference
August 10, 2001 –

Hypertension Diagnostics’ says its CVProfilor^® product launch is meeting company expectations
July 17, 2001 –

Redwood Consultants to Assist with Corporate Communications
July 16, 2001 –

Hypertension Diagnostics’ exhibit is swamped at American Diabetes Association annual meeting in Philadelphia
July 5, 2001 –

Proven Technology Effectively Screens for a Major Indicator of Cardiovascular Disease 
May 30, 2001 –

Ventures Magazine Names Hypertension Diagnostics to its List of Best Performing Small Public Companies in Minnesota 
May 23, 2001 –

Hypertension Diagnostics Demonstrates CVProfilor^® DO-2020 at American Society of Hypertension Annual Meeting
May 18, 2001 –

Hypertension Diagnostics Adds Key Personnel 
to Support Future Growth
May 14, 2001 –

Hypertension Diagnostics Raises $2 million from
Class B Warrant Offering
March 29, 2001 –

Hypertension Diagnostics Announces
CVProfilor^® DO-2020 Launch
March 16, 2001 –

Hypertension Diagnostics Reduces 
Exercise Price of Class B Warrant
March 13, 2001 – 

Hypertension Diagnostics’ Class B Warrants to Commence
Trading on Nasdaq
March 5, 2001 – 

Hypertension Diagnostics Introduces HDI/PulseWave™
Technology in China
March 2, 2001 – 

Hypertension Diagnostics Featured in
THE WALL STREET TRANSCRIPT
February 16, 2001 – 

Hypertension Diagnostics Expects a Significant Increase in Fiscal Year 2001 Revenue
November 8, 2000 – 

Hypertension Diagnostics’ CardioVascular Profiling Technology Advances to a Worldwide Arena
September 8, 2000 – 

Hypertension Diagnostics Announces Effectiveness of 
Registration Statement
August 28, 2000 – 

Hypertension Diagnostics’ Class A 
Warrants Declared Effective by SEC
August 3, 2000 – 

Hypertension Diagnostics’ CardioVascular
Technology Presented at The Annual American
Society of Hypertension Meeting
May 26, 2000 – 

1999

Hypertension Diagnostics Receives ISO 9002/EN-46002 Certification and its HDI/PulseWave™ CR-2000 
Instrument Receives EC Certificate
November 30, 1999 – 

Hypertension Diagnostics Announces Exclusive Distribution Agreement with Higa Medical Systems of Japan
November 30, 1999 – 

Back to Top

Copyright © 2008-2009 Hypertension Diagnostics, Inc
To learn more about HDI, email infoteam@hdii.com 
Last revised Wednesday December 24, 2008